DK0969877T3 - Fremgangsmåder til modulering af væksten af collaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser - Google Patents

Fremgangsmåder til modulering af væksten af collaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser

Info

Publication number
DK0969877T3
DK0969877T3 DK98924093T DK98924093T DK0969877T3 DK 0969877 T3 DK0969877 T3 DK 0969877T3 DK 98924093 T DK98924093 T DK 98924093T DK 98924093 T DK98924093 T DK 98924093T DK 0969877 T3 DK0969877 T3 DK 0969877T3
Authority
DK
Denmark
Prior art keywords
arteries
growth
collateral
arteriolar connections
methods
Prior art date
Application number
DK98924093T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Schaper
Wulf D Ito
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK0969877T3 publication Critical patent/DK0969877T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Liquid Crystal Display Device Control (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DK98924093T 1997-04-04 1998-04-01 Fremgangsmåder til modulering af væksten af collaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser DK0969877T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97105647 1997-04-04
PCT/EP1998/001891 WO1998044953A1 (fr) 1997-04-04 1998-04-01 Procedes servant a moduler la croissance d'arteres collaterales ou d'autres arteres depuis des branchements arteriolaires preexistants

Publications (1)

Publication Number Publication Date
DK0969877T3 true DK0969877T3 (da) 2003-03-24

Family

ID=8226664

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924093T DK0969877T3 (da) 1997-04-04 1998-04-01 Fremgangsmåder til modulering af væksten af collaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser

Country Status (10)

Country Link
US (2) US6592862B1 (fr)
EP (2) EP1304123A3 (fr)
JP (1) JP2001519795A (fr)
AT (1) ATE232399T1 (fr)
CA (1) CA2284922A1 (fr)
DE (1) DE69811348T2 (fr)
DK (1) DK0969877T3 (fr)
ES (1) ES2187972T3 (fr)
PT (1) PT969877E (fr)
WO (1) WO1998044953A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528625B1 (en) 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
WO1999017798A1 (fr) 1997-10-02 1999-04-15 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Procedes de modulation de la neovascularisation et/ou du developpement d'arteres collaterales et/ou d'autres arteres a partir de connexions arteriolaires existantes
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US6312689B1 (en) 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
US6696550B2 (en) 1998-07-23 2004-02-24 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
US6727349B1 (en) 1998-07-23 2004-04-27 Millennium Pharmaceuticals, Inc. Recombinant anti-CCR2 antibodies and methods of use therefor
US6245332B1 (en) 1999-01-15 2001-06-12 The Board Of Trustees Of The Leland Stanford Junior University Modulation of systemic memory T cell trafficking
US6488930B1 (en) 1999-01-15 2002-12-03 Millennium Pharmaceuticals, Inc. Anti-CCR4 antibodies and methods of use therefor
US6329510B1 (en) 1999-01-29 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-CCR1 antibodies and methods of use therefor
WO2000060054A1 (fr) * 1999-04-06 2000-10-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions pharmaceutiques renfermant des cellules de sang circulant, de preference des monocytes et leur utilisation
WO2001087314A1 (fr) * 2000-05-18 2001-11-22 Genetix Pharmaceuticals, Inc. Procedes et compositions destines a promouvoir l'angiogenese au moyen de monocytes
WO2001089565A1 (fr) * 2000-05-19 2001-11-29 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methodes de reduction de la croissance tumorale et de la metastase tumorale par inhibition de l'activite de la proteine chimioattractive monocytaire-1 (mcp-1)
WO2003008005A2 (fr) * 2000-11-08 2003-01-30 Boston Scientific Limited Catheter et implants prevus pour administrer des agents therapeutiques dans les tissus
JP2005508306A (ja) * 2001-07-23 2005-03-31 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 哺乳類における遺伝子発現のＲＮＡｉによる阻害に関する方法および組成物
US10590418B2 (en) 2001-07-23 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for RNAi mediated inhibition of gene expression in mammals
US20040151721A1 (en) 2001-10-19 2004-08-05 O'keefe Theresa Humanized anti-CCR2 antibodies and methods of use therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
EP0767796B1 (fr) * 1994-05-16 2001-09-26 Human Genome Sciences, Inc. Proteine chimiotactique
EP0760682A4 (fr) 1995-02-28 1998-09-09 Univ California Therapie angiogenique par transfert de genes
US6544543B1 (en) * 2000-12-27 2003-04-08 Advanced Cardiovascular Systems, Inc. Periodic constriction of vessels to treat ischemic tissue

Also Published As

Publication number Publication date
WO1998044953A1 (fr) 1998-10-15
EP0969877A1 (fr) 2000-01-12
EP0969877B1 (fr) 2003-02-12
ES2187972T3 (es) 2003-06-16
PT969877E (pt) 2003-06-30
CA2284922A1 (fr) 1998-10-15
DE69811348D1 (de) 2003-03-20
EP1304123A2 (fr) 2003-04-23
DE69811348T2 (de) 2003-12-24
US20040023881A1 (en) 2004-02-05
ATE232399T1 (de) 2003-02-15
US6592862B1 (en) 2003-07-15
EP1304123A3 (fr) 2003-11-19
JP2001519795A (ja) 2001-10-23

Similar Documents

Publication Publication Date Title
DK0969877T3 (da) Fremgangsmåder til modulering af væksten af collaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
DK1019082T3 (da) Fremgangsmåde til moduleringen af neovaskularisering og/eller væksten af kollaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
ES2563677T3 (es) Composiciones de combinaciones de Neisseria
DE60144145D1 (de) Subtilisin-variante
DK161015C (da) Blanding til anvendelse ved ekstern paavisning og lokalisering af en blodprop
CY1115634T1 (el) Μεσα ανταγωνιστικης επιλεκτικης συνδεσης της πρωτεϊνης συνδεσης οστεοπροτεγερινης
DE69733247D1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
EA200000445A1 (ru) Способы лечения состояния гиперкоагуляции или приобретенной недостаточности белка c
BR0211546A (pt) Composição farmacêutica e/ou de diagnóstico e uso de microrganismo ou célula
CY1105364T1 (el) Μεθοδοι και συνθεσεις διαμορφωσης ανοσοποιησης
TW428026B (en) Bifunctional protein, preparation and use
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
ATE490262T1 (de) Abschwächung der immunogenizität von fusionsproteinen
CY1114047T1 (el) Νεοι φορεις εκφρασης και χρησεις αυτων
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
BR9811039A (pt) Citocina de mamìferos: interleucina-b30 e reagentes relacionados
NO920125D0 (no) Fremgangsmaate for aa bestemme den funksjonelle aktivitetentil fri protein s eller protein c i en plasma-proeve
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
AR022236A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
AR022237A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
DE60034966D1 (de) Auswertung von biologischen mitteln in lebenden zielzellen